Investindustrial has held the final close of Investindustrial Growth III above its target at €1.1 billion. The fund will continue the strategy employed by Investindustrial’s previous two funds of making majority investments in European lower mid-market companies with strong internationalisation potential.
Investments will predominantly focus on companies headquartered in Italy, Spain, Portugal or Switzerland.
The fund completed its first investment in Arterex, a global, buy-and-build opportunity in the manufacturing of specialty medical compounds and devices, in Q4 2022.
Investindustrial’s previous two funds have cumulatively invested more than €1.0 billion across 13 platform investments and a further 35 add-on acquisitions, having partnered with investors on several co-investment opportunities.
Paul Hastings (Europe) LLP acted as legal advisor. Crestbridge is acting as fund administrator.
